Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Blink Revitalising Eye Drops
Active Ingredients: Hypromellose 1.5mg/mL
Trometamol 12mg/mL
Tyloxapol 0.25mg/mL
Dosage Form: Contact lens solution
New Zealand Sponsor: Advanced Medical Optics Australia Pty Limited
Manufacturer: Allergan Pharmaceuticals Ireland, Westport, County Mayo, Eire
Product: Myfortic
Active Ingredient: Mycophenolate sodium 192.4mg equivalent to mycophenolic acid 180mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Myfortic
Active Ingredient: Mycophenolate sodium 384.8mg equivalent to mycophenolic acid 360mg
Dosage Form: Enteric coated tablet
New Zealand Sponsor: Novartis New Zealand Limited
Manufacturer: Novartis Pharma Stein AG, Stein, Switzerland
Product: Obix
Active Ingredient: Orlistat 120mg
Dosage Form: Capsule
New Zealand Sponsor: Roche Products (New Zealand) Limited
Manufacturers: F Hoffmann-La Roche Ltd, Basel, Switzerland
Hoffmann-La Roche Inc, Nutley, New Jersey, United States of America
Roche Prodotti SpA, Segrate, Milan, Italy
Dated this 2nd day of May 2004.
DON MATHESON, Deputy Director-General, Public Health (pursuant to delegation given by the Minister of Health on the
6th day of July 2001).